ScienceDex / Researcher record
Beaton, Graham
- Epigen Biosciences, Inc. (no department on record)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2021
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2021 | $1,228,718 | 2 | #7,121 |
| 2022 | $990,691 | 1 | #9,980 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2021 · selected2 records
- FY20221 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award records by amount
NIH award records listing Beaton, Graham as a PI. Multi-PI records show the full award amount for context.
- 1R44DK127879-01A1R44Contact PISelection of a lead LPAR1 antagonist for treatment of diabetic neuropathy$1Maward amount
- 1U18DA052553-01U18Contact PINovel modulators of ÃÂñ7 nAChRs as treatments for nicotine reward$192.9Kaward amount
Award organization
Organizations that administered FY2021 awards listing Beaton, Graham as a PI.
FY2021 award administered by Epigen Biosciences, Inc. (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardEpigen Biosciences, Inc.
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #7121
- 2022$2M Cumulative Funding